This section includes a selection of recorded broadcasts and podcasts from Young & Partners’ conferences, webcasts and other events. The video recordings can be viewed on this website. You can listen to the podcasts via this website or download them via SoundCloud or iTunes.
Young & Partners 2024 Chemical Conference: Speakers Roundtable- What Does the Future Hold?
Joe Chang, Global Editor, ICIS Chemical Business Stephen Floyd, Managing Director, Young & Partners Dewey Johnson, SVP Chemical Market Analytics Lien-Hang T. Nguyen, Director of the Weatherhead East Asian Institute, Columbia University Charlie Vest, Associate Director, China Practice, Rhodium Group Peter Young, President and CEO, Young & Partners
Young & Partners 2024 Chemical Conference: Dewey Johnson: Global Energy & Chemical Markets – Emerging from the Trough
Dewey Johnson, SVP Dow Jones, Global Lead Chemical Market Analytics
Young & Partners 2024 Chemical Conference: Perspectives on Asia and the Middle East and the Impact on Chemicals
Dewey Johnson, SVP & Global Lead, Chemical Market Analytics Lien-Hang T. Nguyen, Director of the Weatherhead East Asian Institute, Columbia University Charlie Vest, Associate Director, China Practice, Rhodium Group Peter Young, President & CEO, Young & Partners
Young & Partners 2024 Chemical Conference: Joe Chang: The Current Challenges and the Future State of the Chemical Industry
Joe Chang, Global Editor, ICIS Chemical Business Peter Young, President and CEO, Young & Partners
Young & Partners 2024 Pharmaceutical Executive Summit: Speakers Roundtable- What Does the Future Hold
Michael Christel, Global Editor, MJH Life Sciences; Fred Hassan, Director, Warburg Pincus; Najat Khan, Chief R&D and Commercial Officer, Recursion; Doug Long, Vice President, Industry Relations, IQVIA; Peter Marks, M.D., Director, Center of Biologics Evaluation and Research, U.S. Food and Drug Administration; Dr. Stephen P. Spielberg, M.D. PhD, Senior Adviser, Young & Partners, former Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration; Sandy Zweifach, President and CBO, IMIDomics; Peter Young, CEO and President, Young & Partners
Young & Partners 2024 Pharmaceutical Executive Summit: Michael Christel and Sandy Zweifach- The Changing Roles and Relationships of Biotech and Pharma
Michael Christel, Global Editor, MJH Life Sciences; Sandy Zweifach, President and CBO, IMIDomics
Young & Partners 2024 Pharmaceutical Executive Summit: Fred Hassan and Najat Khan- The Impact of Artificial Intelligence on the Creation of Medicines
Fred Hassan, Director, Warburg Pincus; Najat Khan, Chief R&D and Commercial Officer, Recursion
Young & Partners 2024 Pharmaceutical Executive Summit: Doug Long: The Pharmaceutical Market: Trends, Issues and Outlook
Doug Long, Vice President, Industry Relations, IQVIA Holdings Inc.
Young & Partners 2024 Pharmaceutical Executive Summit: Peter Marks and Stephen Spielberg Fireside Chat: Brave New World- Where Are We Heading?
Dr. Peter Marks, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration; Dr. Stephen P. Spielberg, MD PhD, Senior Adviser, Young & Partners
Young & Partners 2024 Pharmaceutical Executive Summit: Peter Marks Fireside Chat: Brave New World- Where Are We Heading?
Dr. Peter Marks, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration